The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
Increasing numbers of women are getting additional screenings to rule out breast cancer. But such screenings cost money, out ...
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or ...
Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...
Several key members of the Senate Finance Committee have reintroduced a bill that seeks to establish a Medicare coverage ...
With certain government data currently being withheld, removed, or restored but partially redacted on the websites of ...
A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast ...
The Food and Drug Administration said it was taking the action because studies found that the dye, also known as erythrosine, ...
The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...
After a momentous 2024, Culver City-based ImmunityBio Inc., the immunotherapy company founded and majority-owned by ...
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...